The French government plans to proceed with vaccination of the new coronavirus vaccine developed by British pharmaceutical giant AstraZeneca and others, saying that it has obtained data showing its effectiveness even for people aged 65 and over who had been excluded from vaccination so far. Was shown.
Vaccines developed by AstraZeneca and Oxford University, which Japan also has a contract to supply, have been excluded from vaccination for people aged 65 and over because of lack of efficacy data in France and Germany. ..
In France, on the 3rd, the head of an institution that evaluates medicines etc. held a press conference, and data was reported that it is effective in preventing hospitalization when inoculated by people over 65 years old in Scotland in northern England. Vaccination with Zeneca can be extended to people over the age of 65. "
Health Minister Belan has told local media that people between the ages of 65 and 74 with underlying illness will be vaccinated with the vaccine, targeting 2.5 million new people.
Also in Germany, local media reports that a committee of experts may soon recommend vaccination to people over the age of 65.